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Background: Family physicians should maintain regular contact with obese patients to ensure they effectively
reduce their body weight. However, family physicians in Japan have on average only 6 (min) per consultation,
and conventional interventions for body weight reduction require a longer consultation or additional manpower. A
brief intervention within the limited consultation time available is therefore needed. Here we investigated the
effectiveness of a brief weight reduction intervention for obese patients and the related factors for reducing body
weight during routine consultations in the primary care setting.
Method: We conducted an open-label randomized controlled trial at a family medicine clinic in Fukushima, Japan
from January 2010 to June 2011. Patients aged 30 to 69 years with body mass index ≥25 who were diagnosed with
hypertension, dyslipidemia, and/or type 2 diabetes mellitus were randomly assigned to the intervention or control
group. At every consultation, body weight in the intervention group was measured by a family physician who
provided weight reduction advice in addition to usual care. The primary outcome was body weight change at
1-year follow up. Analysis was done by intention to treat.
Result: We randomly assigned 29 participants to the intervention group and 21 to the control group. Forty participants
(80 %) remained in the trial until the 1-year follow up. At follow up, the median body weight change from
baseline was not significantly different between the groups (p = 0.68), at −0.8 (interquartile range [IQR] −2.5 to 1.0) kg
in the intervention group and 0.2 (IQR −2.4 to 0.8) kg in the control group.
Conclusion: We devised an intervention method for physicians to measure body weight and advise on weight
reduction during routine consultations. In our setting, this method did not extend the consultation time, but also had
no significant additional effects on body weight reduction in moderately obese patients.
Trial registration: This trial is registered with the UMIN Clinical Trial Registry (UMIN000002967).
Keywords: Obesity, Weight reduction, Brief intervention, Primary care, Outpatient care, Short consultationBackground
The number of patients with hypertension, dyslipidemia,
or type 2 diabetes mellitus has increased in the last few
decades in Japan [1]. From 2002 to 2011, the number of
patients with hypertension increased from 7 million to 9
million, those with dyslipidemia from 1.4 million to 1.9* Correspondence: kanke@fmu.ac.jp
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unless otherwise stated.million, and those with type 2 diabetes from 2.3 million
to 2.7 million [1]. All three of these diseases are related
to obesity [2, 3]. In 2008, more than 10 % of the world’s
adult population was obese according to the World
Health Organization’s definition of a body mass index
(BMI) ≥30 kg/m2 [4], although only 3 % of the Japanese
population in 2011 conformed to this definition of obes-
ity [5]. As the incidence rates of obesity-related diseases
in Japan have been increasing, an international expert
panel proposed a lower BMI cut-off for the JapaneseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Japanese is BMI ≥25 kg/m2 [7]. According to this definition,
30 % of Japanese adult men and 21 % of Japanese adult
women were reported to be obese in 2011 [5]. Developing
an effective intervention for reducing the body weight of
obese Japanese patients has the potential to improve the
management of obesity-related diseases.
Although the guidelines for managing overweight and
obesity recommend advising patients with obesity-related
diseases to lose weight [8], the weight reduction approach
of healthcare providers remains inadequate [9]. Primary
care physicians meet many obese patients with obesity-
related diseases [10] and should maintain regular contact
with these patients to ensure they reduce their body
weight as necessary. Epstein and Ogden revealed conflict-
ing points of view between primary care physicians and
obese patients. Obese patients regarded obesity as a med-
ical problem that should be managed by the physicians. In
contrast, physicians consider obesity management to be
primarily the patient’s responsibility. One of the reasons
for this discord is the lack of effective patient interventions
in the primary care setting [11]. In the primary care set-
ting, physicians need a brief and easy-to-perform inter-
vention method for encouraging obese patients to lose
weight. Because physicians manage on average three
problems during each short consultation [12], it is too
difficult to provide the proven intervention methods
established in other studies in a real-world clinical set-
ting. In previous studies conducted in the primary care
setting outside of Japan, patient body weight has been
effectively reduced through lifestyle counseling provided
by medical assistants, nurses, or dietitians [13–15], as well
as by Internet-based intervention programs [16, 17]. In
Japan, providing these interventions in the primary care
setting is difficult because very few dietitians work for pri-
mary care clinics and clinic nurses do not have sufficient
experience in lifestyle counseling. In fact, most lifestyle
counseling is given by Japanese primary care physicians
during regular patient visits [18]. In other studies, physi-
cians have provided tailored intervention to obese patients
during 15 to 20-min long consultations [19, 20]; however,
in Japan, primary care consultations last for around 6 min
[21], meaning that primary care physicians cannot practic-
ally provide any effective counseling-based interventions
due to time constraints. In the Japanese primary care set-
ting, physicians need simple and easy-to-perform methods
of intervention that are suitable for use in routine brief
consultations.
In our clinical experience, some of our obese patients,
whose body weight was checked by the physician at every
consultation, managed to reduce their body weight. Based
on this success, we focused on body weight monitoring
as an innovative method for promoting body weight re-
duction in the primary care setting. In general, weightreduction strategies consist of the following five approaches:
dietary intervention, physical activity, behavioral treatment,
pharmacotherapy, and surgical therapy [3]. Many stud-
ies in the primary care setting have reported the effects
of dietary intervention, physical activity, and pharmaco-
therapy on body weight reduction in obese patients
[13–15]. However, weight monitoring is a component
of behavioral treatment, and in the area of behavioral
treatment, most studies on body weight reduction have
applied an intensive approach in an academic setting;
few studies have reported the effects of behavioral treatment
on body weight reduction in the primary care setting [22].
Against this background, we hypothesized that if phy-
sicians involved in outpatient care measure patient body
weight and advise on weight reduction at every consult-
ation, this approach might reduce the body weight of obese
patients since it can be performed quickly and easily. There
are several important points regarding the approach taken
in this study. First, obese patients should monitor their
weight with their physician since weight monitoring en-
ables obese patients to recognize their actual condition.
We planned weight monitoring with a physician at every
consultation to ensure a sense of urgency and motivation
for lifestyle change. Second, physicians should ask patients
about their lifestyles based on the measured body weight
and provide specific advice on aspects that are difficult to
improve. Third, an intervention method for lifestyle change
is needed to improve doctor-patient relationships [23, 24].
Fourth, we planned to establish a trust relationship by
requesting the physician to advise on the intervention
method. The objective of this study, therefore, was to
devise a brief and easy-to-perform intervention method




We planned an open-label randomized control study at
a family medicine clinic (Date City, Fukushima Prefecture,
Japan) attended by four family physicians. Date city is lo-
cated 250 km north of Tokyo, its population was about
66,000 people in 2010, and main industry of the city is
agriculture. From January to June 2010, we checked the
medical records of adult patients aged 30–69 years who
visited the family medicine department for routine checkups
for hypertension, dyslipidemia, and/or type 2 diabetes
mellitus. A total of 180 patients were matched in January
2010. From the pool, we recruited 57 patients with a
BMI ≥25 kg/m2 (moderately to severely obese) to par-
ticipate in this study. We excluded patients with a history
of cancer or psychological disease, or those prescribed hor-
mone therapy because these factors are known to affect
body weight [25–27]. We informed all participants of the
aim and content of the study, and obtained their written
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project, 51 patients agreed to participate. One participant
with a history of cancer was excluded. At baseline measure-
ment, 50 participants (18 women, 36 %; 32 men, 64 %) were
enrolled. We randomized 29 participants to the interven-
tion group and 21 participants to the control group. In
total, 44 participants (88 %) were assessed for body weight
changes at 6 months, and 40 participants (80 %) remained
in the study until the 1-year follow up (Fig. 1).
Baseline data and measurement
After the participants agreed to participate, their physician
collected the following baseline data: age, sex, history of
hypertension (yes or no), history of dyslipidemia (yes or
no), history of type 2 diabetes (yes or no), educational
background (junior high school, high school, technical
college, or university), history of smoking (never smoker,
former smoker, or current smoker), history of alcohol
consumption (never drinker, <once a week, <3 times per
week, <6 times per week, or daily), and frequency of body
weight self-monitoring (<once a month, <once a week,
several times per week, or daily).
Nurses, who were blinded to the group assignment of
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Fig. 1 Participant flow chartabdominal circumference, and blood pressure. After defe-
cating and urinating, participants removed their shoes and
wore as light clothing as possible for height and body
weight measurement on a digital scale. Abdominal circum-
ference was measured at the umbilical level with a tape
measure in the standing position and at end-expiratory
pressure [28], and blood pressure was measured in the sit-
ting position with an automated sphygmomanometer after
a few minutes rest. We checked these data and the partici-
pants’ medical records to ensure the participants met the
criteria for metabolic syndrome (Japanese criteria and the
National Cholesterol Education Program-Adult Treatment
Panel III criteria) [28, 29].Randomization
Participants were assigned original identification numbers,
which were sent to a co-researcher (AI) working at an-
other hospital who randomized these numbers into two
groups (intervention group and control group) by means
of a table of random numbers. The randomization results
were sent to the chief researcher (SK) who informed the
participants. Figure 1 shows the participant flow through-
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In the intervention group, at the first consultation after
randomization, participants were informed about their
ideal body weight, weight reduction target (5 % of current
weight), and the positive effect of weight reduction for
their current diseases by the physician, who provided
them with an information leaflet [30]. Participants were
also informed that a physician would check their body
weight and provide specific advice on weight reduction
at every regular consultation. Thereafter, the participants
received care for their current diseases based on the
Japanese guidelines for hypertension, dyslipidemia, and
type 2 diabetes [31–33] every 1 or 2 months. A physician
measured body weight after defecation and micturition
using an analogue scale at every consultation and provided
advice in relation to the changes of measured body weight
at each consultation. In addition, at every consultation,
the physician was required to specifically question the pa-
tient on eating and exercise, to reconfirm the patient’s
weight target, and to provide advice focusing on each
participant’s difficulties in lifestyle change. We requested
all physicians to perform this intervention, even if the con-
sultation duration exceeded the usual appointment time
(Table 1).
In the control group, at the first consultation after
randomization, participants were informed of their ideal
body weight, weight reduction target, and positive effect




Explanations were given on the following:
Ideal body weight (body mass index, 22 kg/m2) and wei
reduction target of each participant (5 % body weight).
The positive effect of weight reduction for the participan
present disease.
A physician measured the participant’s body weight and




Routine consultations were performed every 1 or 2 m
for the participant’s present disease based on the guid
for the disease.
Body weight was measured.
The physician questioned the patient on key lifestyle f
weight reduction (i.e., eating, exercising, and weight m
The physician provided information on the following s
lifestyle changes for obese people:
Calorie intake (reduce calorie intake to 25 kcal/kg ideal b
weight/day).
Eat a well-balanced diet (calorie balance: protein, 10-15
20-25 %, and carbohydrate, 60 %).
Exercise for 20-30 min at least three times per week.
The physician provided advice focusing on weight red
adjusted to each participant’s circumstances and lifestThereafter, participants received care for their current
diseases based on the Japanese guidelines every 1 or 2
months. However, the physician was not required to meas-
ure body weight or discuss body weight reduction at every
consultation.
Outcomes
The primary outcome of this study was change in body
weight at 1-year follow up. Secondary outcomes were
changes in body weight at 6-month follow up, and changes
in abdominal circumference and blood pressure at the 6-
month and 1-year follow ups. Nurses blinded to the group
assignment of each patient measured body weight, abdom-
inal circumference, and blood pressure at 6 months and 1
year. The nurses then asked the participants about their
frequency of weight self-monitoring at the 1-year follow up
using the same classification as that used at baseline. Physi-
cians recorded the length (in minutes and seconds) of each
consultation and calculated the mean length for each
patient after all participants had completed the 1-year
follow up.
Sample size calculation
We selected a mean weight difference of 2 kg after 1
year as clinically significant and assumed a standard de-
viation of weight change of 2 kg, in accordance with a
previous study [34]. The present study was designed to
have an 80 % power to detect a weight change of 2 kg inControl group
Explanations were given on the following:
ght Ideal body weight (body mass index, 22 kg/m2) and weight
reduction target of each participant (5 % body weight).
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Table 2 Baseline demographic and clinical characteristics of participants
n (%) or Median (interquartile range)
Intervention Control p value
n = 29 n = 21
Age (years) 56 (38 to 65) 55 (42 to 63) 0.94
Sex 0.39
Female 9 (31) 9 (43)
Male 20 (69) 12 (57)
Weight (kg) 71.8 (67.3 to 82.4) 74.1 (68.1 to 77.4) 0.84
Height (cm) 164.5 (156.5 to 168.3) 162.5 (154.5 to 168.1) 0.79
BMI (kg/m2) 27.6 (26.4 to 29.5) 27.6 (26.9 to 28.4) 0.78
Abdominal circumference (cm) 94.0 (91.8 to 98.0) 95.0 (92.0 to 97.5) 0.93
Blood pressure
Systolic blood pressure (mmHg) 130 (120 to 140) 132 (120 to 138) 0.85
Diastolic blood pressure (mmHg) 82 (72 to 86) 78 (71 to 86) 0.88
Serum lipid profile
Low-density lipoprotein (mg/dl) 128 (101 to 147) 126 (103 to 148) 0.86
High-density lipoprotein (mg/dl) 56 (45 to 61) 53 (45 to 62) 0.85
Triglyceride (mg/dl) 117 (88 to 171) 109 (88 to 126) 0.52
Fasting blood sugar (mg/dl) 100 (95 to 109) 102 (95 to 117) 0.42
Hemoglobin A1c (%) 5.5 (5.2 to 5.9) 5.7 (5.3 to 6.2) 0.15
Regular medication
Antihypertensive drug 24 (82) 15 (71) 0.49
Lipid-lowering drug 9 (31) 7 (33) 0.86
Anti-diabetic drug 0 (0) 5 (24) 0.01
Medical history
Hypertension 25 (86) 17 (81) 0.71
Dyslipidemia 11 (38) 8 (38) 0.99
Type 2 diabetes mellitus 2 (7) 6 (29) 0.06
Metabolic syndrome criteria
Japanese criteria 15 (52) 6 (29) 0.10
NCEP-ATP III criteria 15 (52) 7 (33) 0.20
Educational background 0.48
Under high school 7 (24) 7 (33)
High school and above 22 (76) 14 (67)
Smoking 0.87
Non-smoker 24 (83) 17 (81)
Currently smoker 5 (17) 4 (19)
Alcohol drinking 0.53
Under once a week 14 (48) 12 (57)
Once a week or more 15 (52) 9 (43)
Weight self monitoring frequencya 0.73
Under once a week 14 (48) 11 (52)
Once a week or more 14 (48) 9 (43)
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Table 2 Baseline demographic and clinical characteristics of participants (Continued)
Home blood pressure monitoring 0.19
Regularly 24 (83) 14 (67)
Not regularly 5 (17) 6 (33)
We compared groups with the Mann–Whitney U test or Chi-squared test
BMI, body mass index; NCEP-ATP, Cholesterol Education Program-Adult Treatment Panel
aData were missing for one patient in the intervention group and one patient in the control group
Table 3 Regular prescription drugs change between baseline
and the 1-year follow up
Number of participants, n (%)
Intervention group Control group
n = 22 n = 18
Antihypertensive drugs
Increase 1 (5) 5 (28)
Stable 21 (95) 13 (72)
Decrease 0 0
Lipid-lowering drug
Increase 3 (14) 1 (6)
Stable 19 (86) 17 (94)
Decrease 0 0
Anti-diabetic
Increase 0 1 (6)
Stable 22 (100) 16 (88)
Decrease 0 1 (6)
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were needed in each group. We considered p <0.05 as
statistically significant.
Blinding
We informed the participants and the physicians, but
not the nurses, of the randomization results at the first
consultation after randomization. No measurement data
were given to the physicians. Analysis was performed
after all data had been collected.
Statistical analyses
Analysis was based on the intention-to-treat principle.
The categorical variables of baseline data were converted
into binary categories, education background (<high school
or ≥ high school), history of smoking (nonsmoker or
currently smoker), history of drinking alcohol (<once a
week or ≥ once a week), and frequency of body weight
self-monitoring (<once a week or ≥ once a week). We
analyzed baseline data between the two participant groups
using the Mann–Whitney U test and Chi-squared test.
The main outcome and secondary outcomes were ana-
lyzed using the Mann–Whitney U test. Statistical analysis
was performed using SPSS Statistics (version 17.0; SPSS
Inc, Chicago, IL).
Ancillary analyses
Further analyses were conducted on the associations be-
tween body weight change and consultation factors. Data
of 40 participants, regardless of their randomization group,
who completed the 1-year follow up were used. We fo-
cused on the consultation factors, which included the
number of consultations over 1 year, total length of
consultations over the year, mean length of each consult-
ation, and number of physicians who saw participants in
the clinic over the year, in order to calculate the total con-
sultation length over the year and the mean length of each
consultation. The number of physicians who saw partici-
pants was obtained from the medical records. The associa-
tions of these factors with the change in body weight over
the 1-year period were analyzed using Spearman’s rank
correlation coefficient.
In another ancillary analysis, we focused on the weight
self-monitoring factors, which included their frequency
and change over the 1-year period. From the self-reported
weight self-monitoring frequency at baseline and at the1-year follow up, we divided the participants into the
following two groups based on change in weight self-
monitoring frequency: those with a decreased fre-
quency (decreased group), and those with an increased
or unchanged frequency (non-decreased group). We
then analyzed the relationship between amount of body
weight change at 1 year and the frequency, or change
in the frequency, of weight self-monitoring over the
year. Data were analyzed using the Kruskal-Wallis test
and the Mann–Whitney U test.
This study was approved by the Ethics Board of
Fukushima Medical University (No. 905) and is registered
in the UMIN Clinical Trial Registry (UMIN 000002967).
Results
For participants in both groups, the mean age (SD) was
54.8 (6.7) years, mean body weight (SD) was 74.1 (9.6) kg,
and mean BMI (SD) was 28.1 (2.1) kg/m2. At baseline, no
significant differences were evident between the groups
(Table 2). In one year follow-up period, 12 participants
changed regular prescription drugs (Table 3). The median
number of consultations (interquartile range [IQR]) was 8
(7 to 10) in the intervention group and 10 (9 to 11) in the
control group. The median consultation length (IQR) for
each patient over the 1-year period was 59.1 (51.4 to 71.1)
Table 4 Consultation factors in the intervention and control groups
Median (interquartile range)
Intervention group Control group p value
n = 22 n = 18
Number of consultations in one year 8 (7 to 10) 10 (9 to 11) 0.01*
Total consultation duration in one year (min) 59.1 (51.4 to 71.1) 79.7 (64.8 to 97.8) 0.002*
Average duration of consultation (min) 7.0 (6.3 to 8.0) 8.0 (6.3 to 9.9) 0.13
We compared groups with the Mann–Whitney U test
*Significantly different (p <0.05) between the groups
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in the control group. The median length (IQR) of each
consultation was 7.0 (6.3 to 8) min in the intervention
group and 8.0 (6.4 to 9.8) min in the control group. The
median number of doctors (IQR) who saw each partici-
pant over the 1-year period was 2 (1 to 3) in the interven-
tion group and 2 (1 to 3) in the control group. The
number of consultations (p = 0.01) and the total consult-
ation length (p = 0.002) were significantly different in both
groups. The length of each consultation was not signifi-
cantly different (p = 0.13) (Table 4).
Intention-to-treat analysis revealed that at 1 year, 15
participants in the intervention group (68 % of the group)
and 9 participants in control group (50 % of the group)
had decreased their body weight from baseline values.
The median (IQR) change in body weight from baseline
was −0.8 (−2.5 to 1.0) kg in the intervention group and
0.2 (−2.4 to 0.8) kg in the control group. There was no
significant difference in this primary outcome (p = 0.68)
observed between the groups (Fig. 2).Fig. 2 Box plots of body weight change at the 1-year follow upNo significant differences in secondary outcomes were
noted between the groups; that is, the median (IQR)
changes in the intervention and control groups at the
1-year follow up were 0.0 (−3.5 to 1.5) cm and −1.2
(−2.8 to 1.0) cm for abdominal circumference, 2 (−12 to
10) mmHg and −1 (−10 to 7) mmHg for systolic blood
pressure, and −2 (−6 to 4) mmHg and −2 (−10 to 8)
mmHg for diastolic blood pressure, respectively. The me-
dian (IQR) changes in the intervention and control groups
at 6 months were −1.0 (−2.3 to 0.6) kg and −1.9 (−3.8 to
0.6) kg for body weight, −1.1 (−2.4 to 0.9) cm and −2.8
(−4.0 to −0.4) cm for abdominal circumference, 0 (−6 to 9)
mmHg and 0 (−15 to 7) mmHg for systolic blood pressure,
and −1 (−6 to 7) mmHg and −2 (−10 to 7) mmHg for
diastolic blood pressure, respectively (Fig. 3). Again, no
significant differences were observed between the groups.
Ancillary analyses
In analysis of consultation factors, the mean number of
consultations (SD) was 9.1 (2.1), mean total consultation
Body weight 
Abdominal circumference 
Systolic blood pressure 
Diastolic blood pressure 
Fig. 3 Box plots of secondary outcomes
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of each consultation (SD) was 7.8 (2.2) min, and mean
number of physicians who saw each participant (SD)
was 2.1 (1.0). The correlation coefficient was 0.16 (p =
0.31) for body weight change and the number of con-
sultations, 0.32 (p = 0.05) for body weight change and
the total consultation length, 0.30 (p = 0.06) for body
weight change and length of each consultation, and −0.01
(p = 0.93) for body weight change and the number of phy-
sicians who saw each participant. A weak positive correl-
ation was seen between body weight change and total
consultation length over the year.In another ancillary analysis about body weight self-
monitoring, at baseline, weight self-monitoring was per-
formed less than once a month by 13 (33 %) participants,
less than once a week by 8 (20 %) participants, several
times per week by 11 (28 %) participants, and daily by 8
(20 %) participants. The median (IQR) of body weight
change at the 1-year follow up was −0.6 (−2.7 to 0.7) kg in
participants self-monitoring less than once a month, −0.4
(−2.2 to 0.9) kg in those self-monitoring less than once a
week, −1.7 (−2.9 to 1.1) kg in those self-monitoring several
times per week, and −1.3 (−2.7 to 1.1) kg in those self-
monitoring daily (Fig. 4). Analysis using the Kruskal-Wallis
test showed no significant differences (p = 0.86). We
calculated the change in the frequency of weight self-
monitoring from baseline to the 1-year follow up (Table 5).
Eight participants (21 %) had decreased their frequency of
weight self-monitoring, 20 (54 %) showed no change, and
9 (24 %) had increased their frequency at the 1-year follow
up. We analyzed body weight change over the 1-year
period between the decreased group (n = 8) and the non-
decreased group (n = 29). The median (IQR) changes in
body weight between baseline and the 1-year follow up
were −1.8 (−2.7 to 0.6) kg in the non-decreased group and
0.9 (−0.4 to 1.8) kg in the decreased group, a significant
difference (p = 0.009) between the groups (Fig. 5).
It should be noted that the study area was affected by
the Great East Japan Earthquake in March 2011, which
occurred during the study period. In the aftermath, both
water and gasoline were in short supply, which forced
some participants to evacuate to community halls for
several days. The 1-year follow up for 11 participants of
the intervention group (50 % of the group) and 9 in the
control group (50 % of the group) (total 20; 50 %) was
done after the earthquake, and we analyzed the effect of
the earthquake on body weight change using the Mann–
Whitney U test (Table 6). No significant differences were
observed in body weight change between the participants
who attended the 1-year follow up before the earthquake
and those who attended after it (p = 0.95).Discussion
We planned this study to reveal the effects on obese
Japanese patients of adding a brief intervention for body
weight reduction to routine consultations with a physician.
We accomplish the randomized controlled trial at a family
medicine clinic in the primary care setting. Given the lower
incidence rate of severe obesity in Japan than in developed
Western countries [1, 4], we need an intervention method
that not only addresses severe obesity, but also overweight
and moderate obesity. In this study, only 8 participants
(16 %) were severely obese (BMI ≥30, Japanese criteria),
and the average BMI was 28.1, which is classed as mod-
erately obese.
Fig. 4 Box plots of body weight change at the 1-year follow up in relation to the frequency of self-monitoring at baseline
Kanke et al. Asia Pacific Family Medicine  (2015) 14:5 Page 9 of 12Our results revealed no significant differences in con-
sultation length between the intervention and control
groups. This intervention method was performed briefly
as planned and proved suitable for short routine consul-
tations. It is noteworthy that the present intervention
method is feasible for short routine consultations in the
real-world clinical setting.
The total consultation length was unexpectedly longer
in the control group than in the intervention group. The
consultation length for the control group might have
been longer because the control group had a higher ratio
of participants who gained body weight. A possible ex-
planation for this finding is that physicians may have
extended the duration of each consultation for patients
who gained weight and may have kept consultations
short for patients who maintained or lost weight. Alter-
natively, physicians may have extended the consultation
time in general to measure body weight and provide ad-
vice to patients in the intervention group within the
short consultation time allotted and in doing so mightTable 5 Comparison of body weight self-monitoring frequency at b
Number of participants, n (%
Frequency of body weight s
<Once a month <O
Frequency at Baseline <Once a month 6 (16) 3
<Once a week 3 (8) 3
>Once a week 2 (5) 2
Daily 0 (0) 1
Total 11 (30) 9have unintentionally overlooked other aspects of care
while being preoccupied with the measurement, keep-
ing the consultation time shorter for the intervention
group overall.
Although we planned a brief and easy-to-perform inter-
vention method for body weight reduction, no significant
additional effects on usual care were observed. On the
other hand, the result does not deny effect of all other
simple low cost interventions. Brief advice provided by
physicians has been effective for quitting smoking [35]
in the primary care setting, and simple intervention methods
used by primary care physicians to encourage patients to
quit smoking have been established [36]. Weight reduction
is more complex than smoking cessation in two regards.
First, smoking is not essential to survival. Physicians, there-
fore, can provide clear advice to stop smoking. On the other
hand, patients cannot simply stop eating. Physicians can,
however, advise on how to eat. Quitting a behavior can
be a simpler approach than finding an appropriate way
to adjust a behavior. Second, is the nature of underlyingaseline and at the 1-year follow up
)
elf-monitoring at the 1-year follow up
nce a week >Once a week Daily Total
(8) 1 (3) 1 (3) 11 (29)
(8) 2 (5) 0 (0) 8 (22)
(5) 5 (14) 2 (5) 11 (29)
(3) 0 (0) 6 (16) 7 (19)
(24) 8 (22) 9 (24) 37 (100)
Fig. 5 Box plots of body weight change in 1-year follow up by body weight self-monitoring frequency
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factor for health, physicians can focus their advice dir-
ectly on smoking behavior. On the other hand, obesity
is a biomedical condition resulting from the interac-
tions between social, behavioral, cultural, physiological,
metabolic, and genetic factors [37]. To successfully re-
duce weight, obese patients need to change their eating,
exercising, working, and other behaviors. Consequently,
physicians need to intervene in multiple factors for
weight reduction when dealing with obese patients.
Multiple categories of intervention for body weight re-
duction are available. The intervention method used in
this study was based on a behavioral approach, for which
we attached high value to an easy-to-perform method.
Previous studies have shown that intervention methods
involving multiple approaches for weight reduction
are more effective than those with a single approach
[14, 38, 39]. Thus, to develop an effective intervention
method for reducing body weight during short, primaryTable 6 Comparison of weight change at the 1-year follow up betw
Before
Intervention group Number of participants 9
Weight change (kg)a −0.4 k
Control group Number of participants 11
Weight change (kg)a −1.0 k
Total Number of participants 20
Weight change (kg)a −0.7 k
aMean weight change between baseline and the 1-year follow upcare consultations, it may be useful to encompass multiple
brief and easy-to-perform approaches suited to short
consultations.
The approach of our clinic may affect outcomes. As
effective doctor-patient communication can improve
patient health outcomes [24], family medicine trainees
need to improve their skills in doctor-patient commu-
nication during residency training. The family medicine
clinic, which served as a teaching clinic in the family
medicine residency program, had four family physicians.
One of the physicians was a faculty member and the other
three were senior trainees of family medicine. In this case,
more experienced family physicians could have made the
difference in the intervention method.
As another consideration for devising a brief and easy-
to-perform intervention method, we noted weight self-
monitoring. In a previous study, Butryn and colleagues
showed that more frequent body weight self-monitoring
is related to body weight maintenance in patients whoeen before and after the Great East Japan Earthquake
Total
the earthquake After the earthquake
9 18
g −0.7 kg −0.5 kg
11 22
g −0.6 kg −0.8 kg
20 40
g −0.6 kg −0.7 kg
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that weight self-monitoring increases obese patients’
awareness of their weight and results in them modifying
their eating and exercise behavior [41]. The result of
ancillary analysis revealed the relationship between
self-monitoring frequency at baseline and body weight
reduction, as well as that between change in body weight
self-monitoring frequency and body weight reduction.
We, therefore, consider it worthwhile to explore this
relationship further in a future prospective study.
This study has several limitations. First, it was con-
ducted at a single family medicine clinic, where it was
difficult to analyze subjects by sex, age, and other factors
due to the number of eligible patients. If the number of
participants had been larger, we might detect modest
weight reduction. And if the observation period had
been longer, we might detect long-term weight change.
In real primary care setting, even if effect sizes are small,
simple low-cost intervention methods can be used with-
out too much difficulty for years and, therefore, they are
of benefit to the patients. A cluster randomized con-
trolled multicenter design is a possible solution for as-
sembling more participants and acquiring more evidence
with greater power. The second limitation is that this
study was conducted in the Japanese clinical setting,
which differs from that in Western countries in terms of
shorter and more frequent consultations. The third limi-
tation is that the intervention method was affected by
doctor-patient communication as we did not strictly
standardize the weight reduction advice provided by the
physicians. This might have resulted in inter-physician
differences in the intervention, which were not measured.
If we had evaluated doctor-patient communication, we
would have been able to take variables of patients’ view-
point. The fourth limitation is that this study did not have
data about diet and exercise. We could not analyze
about food choice and other actions of the participants.
A final limitation is the effects of the Great East Japan
Earthquake. In particular, we could not eliminate the effects
of the earthquake because of the small study population.Conclusions
We studied the intervention method used by physicians
to measure body weight and advise patients on weight
reduction during routine consultations. In our setting,
this method did not extend the consultation duration,
but also had no significant effects on body weight reduc-
tion in moderately obese patients. Therefore, additional
studies on simple and easy-to-perform intervention methods
are needed. Taken together, the present findings revealed a
potential research question on the relationship between
weight self-monitoring and body weight reduction in
the primary care setting.Competing interests
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